Propylactic Use of Entecavir for Biological Agents Associated Hepatitis B Virus Reactivation in Inflammatory Arthritis Patients: a Randomized Controlled Trial
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 18 Mar 2019
Price : $35 *
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 11 Mar 2019 Planned End Date changed from 1 Dec 2018 to 31 Dec 2019.
- 11 Mar 2019 Status changed from recruiting to active, no longer recruiting.
- 31 Mar 2016 Planned End Date changed from 1 Jul 2016 to 1 Dec 2018 as per ClinicalTrials.gov record.